AnaptysBio, Inc.

US$46.45As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ANABHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 15.57%
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.37
PE TTM 6.637
TSR TTM 90.50%
Mkt cap US$1.389B
ROIC 56.62%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$46
(1.20%)
(54.18%)
Hold 8|6|9|2|3
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.47
0.46
0.46
0.45
15.18%
15.42%
5.85%
3.30%
Revenue$M
67.25
70.16
73.73
72.74
7.91%
8.57%
16.80%
8.89%
Peers (US$1.389B)
Cap (US$)
PE
1.358B
7.510x
Capital
TTM
5Y
10Y
Leveragex
0.468
—
—
EBIT/Intx
1.157
0.859
0.810
Own earn%
81.08
(123.42)
(102.11)
Sh yield%
14.41
54.06
53.86
Owners
Insiders/Inst%
6.59
67.70
Short interest%
4.12
SBC / revenue%
0.36
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
14–22
$1 testx
0.0
Incr. ROIC%
4